Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Violette

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Chemistry & Biology|March 14, 2000
A Src SH2 selective binding compound inhibits osteoclast-mediated resorptionS M Violette, W C Shakespeare, C Bartlett, et al.
Journal of Medicinal Chemistry|October 29, 2000
Structure-based design of novel bicyclic nonpeptide inhibitors for the src SH2 domainW C Shakespeare, R S Bohacek, M D Azimioara, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 15, 2013
Inhibition of αvβ6 promotes acute renal allograft rejection in nonhuman primatesD J Lo, A B Farris, M Song, et al.
Journal of Medicinal Chemistry|March 23, 2001
X-Ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitorR S Bohacek, D C Dalgarno, M Hatada, et al.
Bone|February 13, 2001
Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorptionS M Violette, W Guan, C Bartlett, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Chemistry & Biology|March 14, 2000
A Src SH2 selective binding compound inhibits osteoclast-mediated resorptionS M Violette, W C Shakespeare, C Bartlett, et al.
Journal of Medicinal Chemistry|October 29, 2000
Structure-based design of novel bicyclic nonpeptide inhibitors for the src SH2 domainW C Shakespeare, R S Bohacek, M D Azimioara, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 15, 2013
Inhibition of αvβ6 promotes acute renal allograft rejection in nonhuman primatesD J Lo, A B Farris, M Song, et al.
Journal of Medicinal Chemistry|March 23, 2001
X-Ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitorR S Bohacek, D C Dalgarno, M Hatada, et al.
Bone|February 13, 2001
Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorptionS M Violette, W Guan, C Bartlett, et al.
Pageof 2